Taiwan Liposome Ltd.

NASDAQ: TLC · Real-Time Price · USD
7.00
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Taiwan Liposome Income Statement

Financials in TWD. Fiscal year is January - December.
Fiscal Year Q2 2021 Q1 2021
Period Ending Jun 30, 2021 Mar 31, 2021
Revenue
275.97M 127.57M
Cost of Revenue
n/a n/a
Gross Profit
275.97M 127.57M
Operating Income
-821.57M -986.63M
Interest Income
n/a n/a
Pretax Income
-819.07M -986.01M
Net Income
-803.16M -970.09M
Selling & General & Admin
136.07M 143.94M
Research & Development
989.71M 998.5M
Other Expenses
-28.23M -28.23M
Operating Expenses
1.1B 1.11B
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
1.1B 1.11B
Income Tax Expense
965K 950K
Shares Outstanding (Basic)
42.08M 42.13M
Shares Outstanding (Diluted)
42.08M 42.13M
EPS (Basic)
-19.09 -23.86
EPS (Diluted)
-19.09 -23.86
EBITDA
-789.7M -956.64M
EBIT
-577.96M -743.02M
Depreciation & Amortization
21.83M 19.95M